Quoin Pharmaceuticals, Ltd. (QNRX) can sell. Click on Rating Page for detail.
The price of Quoin Pharmaceuticals, Ltd. (QNRX) is 9.2 and it was updated on 2025-07-11 13:00:27.
Currently Quoin Pharmaceuticals, Ltd. (QNRX) is in undervalued.
News |
---|
![]() Quoin Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
|
![]() Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign
|
![]() Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
|
![]() Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases
|
![]() Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
|
Transcipts Data |
---|
![]() Quoin Pharmaceuticals, Ltd. (QNRX) on Q4 2023 Results - Earnings Call Transcript
|
![]() Quoin Pharmaceuticals, Ltd. (QNRX) on Q3 2023 Results - Earnings Call Transcript
|
![]() Quoin Pharmaceuticals, Ltd. (QNRX) on Q2 2023 Results - Earnings Call Transcript
|
![]() Quoin Pharmaceuticals, Ltd. (QNRX) on Q1 2023 Results - Earnings Call Transcript
|
![]() Quoin Pharmaceuticals, Ltd. (QNRX) on Q4 2022 Results - Earnings Call Transcript
|
![]() Quoin Pharmaceuticals, Ltd. (QNRX) on Q3 2022 Results - Earnings Call Transcript
|
![]() Quoin Pharmaceuticals, Ltd. (QNRX) on Q2 2022 Results - Earnings Call Transcript
|
StockPrice Release |
---|
News |
---|
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications
|
Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study
|
Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome
|
Quoin Pharmaceuticals Launches ‘NETHERTON NOW' Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure
|
Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome
|
Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
|
PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials
|
Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study
|
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
|
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
|
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies
|
Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
|
Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO
|
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results
|
Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
|
Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024
|
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
|
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
|
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
|
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
|
Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcript
|
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
|
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
|
Why Is Quoin Pharmaceuticals (QNRX) Stock Down 50% Today?
|
Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
|
PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan
|
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
|
Quoin Pharmaceuticals, Ltd. (QNRX) Q3 2023 Earnings Call Transcript
|
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results
|
Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET
|
REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
|
Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
|
Quoin Pharmaceuticals, Ltd. (QNRX) Q2 2023 Earnings Call Transcript
|
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Results
|
Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today?
|
Quoin Pharmaceuticals Announces 2022 Corporate Update Conference Call to be held on Thursday March 9th at 8:30am ET
|
Quoin Pharmaceuticals, Ltd. (QNRX) Q3 2022 Earnings Call Transcript
|
Quoin Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10th
|
10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022
|
7 Penny Stocks To Buy According To Top Wall Street Analysts
|
Hot Penny Stocks To Watch Today As Stock Market Crash Continues
|
4 Penny Stocks Making A Comeback In September, Time To Buy?
|
Quoin Pharmaceuticals, Ltd. (QNRX) CEO Michael Myers on Q2 2022 Results - Earnings Call Transcript
|
Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th
|
Why Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today?
|
Best Penny Stocks To Buy Right Now? 4 To Watch Under $1
|
Penny Stocks To Buy Now? 4 To Watch With Big News
|
Why Quoin Pharmaceuticals Stock Is Trading Higher
|
Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today
|
Best Penny Stocks to Buy as 2021 Ends? 3 to Watch Right Now
|